ATE188706T1 - Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels - Google Patents

Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels

Info

Publication number
ATE188706T1
ATE188706T1 AT92115730T AT92115730T ATE188706T1 AT E188706 T1 ATE188706 T1 AT E188706T1 AT 92115730 T AT92115730 T AT 92115730T AT 92115730 T AT92115730 T AT 92115730T AT E188706 T1 ATE188706 T1 AT E188706T1
Authority
AT
Austria
Prior art keywords
producing
nuclear inhibitor
medicinal product
nuclear
inhibitor
Prior art date
Application number
AT92115730T
Other languages
English (en)
Inventor
Juergen Weitz
Michael Stoehr
Inge Napierski
Hans-Dieter Royer
Marijana Kopun
Original Assignee
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg Gmbh filed Critical Dade Behring Marburg Gmbh
Application granted granted Critical
Publication of ATE188706T1 publication Critical patent/ATE188706T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92115730T 1991-10-09 1992-09-15 Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels ATE188706T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91117184 1991-10-09

Publications (1)

Publication Number Publication Date
ATE188706T1 true ATE188706T1 (de) 2000-01-15

Family

ID=8207249

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92115730T ATE188706T1 (de) 1991-10-09 1992-09-15 Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels

Country Status (8)

Country Link
US (1) US6045831A (de)
EP (1) EP0536563B1 (de)
JP (1) JPH06245787A (de)
AT (1) ATE188706T1 (de)
AU (1) AU669129B2 (de)
CA (1) CA2080182C (de)
DE (1) DE69230550T2 (de)
ES (1) ES2140402T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0744808B2 (ja) * 1987-02-19 1995-05-15 ▲えな▼吉 早坂 磁気制御同性磁極誘導発電機
US20040022764A1 (en) * 2002-07-31 2004-02-05 Hanan Polansky Inhibition of microcompetition with a foreign polynucleotide as treatment of chronic disease

Also Published As

Publication number Publication date
EP0536563B1 (de) 2000-01-12
ES2140402T3 (es) 2000-03-01
CA2080182A1 (en) 1993-04-10
DE69230550D1 (de) 2000-02-17
AU669129B2 (en) 1996-05-30
JPH06245787A (ja) 1994-09-06
US6045831A (en) 2000-04-04
AU2627892A (en) 1993-04-22
CA2080182C (en) 2002-12-10
EP0536563A1 (de) 1993-04-14
DE69230550T2 (de) 2000-05-25

Similar Documents

Publication Publication Date Title
ATE91399T1 (de) Matrize fuer die dentalmedizin und eine vorrichtung zur herstellung von matrizenbaendern.
BR9206027A (pt) Análogo de oligonucleotídio, composto de subunidade de oligonucleotídeo, processo para preparar tal composto, processo para modular a produção ou atividade de uma proteína, e, processo para tratar um organismo tendo uma doença distinta pela produção indesejada de uma proteína
DE69825292D1 (de) Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen
DE69913665D1 (de) Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten
ATE237303T1 (de) Verwendung von zusammensetzungen mit benzoylperoxyd, glycolsäure und zink zur behandlung von dermatologischen krankheiten
EP0787802A3 (de)
DE3784693D1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE68924714D1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
ATE307203T1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
ATE79254T1 (de) Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
ATE188706T1 (de) Kernhemmstoff i-92 und seine verwendung zur herstellung eines arzneimittels
MX9200106A (es) Depresor anatomico lingual, desechable y esteril, para la exploracion del istmo de las fauces y la laringe
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
DE19681032D2 (de) Gentherapeutisches Nukleinsäurekonstrukt, seine Herstellung und Verwendung zur Behandlung von Herzerkrankungen
DE3686019D1 (de) Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE69133074D1 (de) Einen basischen Fibroblastwachstumsfaktor enthaltende Mittel zur Behandlung von Knochenkrankheiten
DE3873188D1 (de) Verwendung von nigerizin zur herstellung eines mittels zur behandlung von virus-erkrankungen.
DE3790919T1 (de) Arzneimittel zur prophylaxe und behandlung von gastrointerfinalen erkrankungen des landwirtschaftsviehs
ZA878117B (en) A process for the production of substances that have been bactericidally treated and-or exhibit immunomodulatory activity,and the use thereof
DE69424415D1 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee